The pathology specimen demonstrated a renal cell carcinoma, grade IV/IV, 9 cm, T4 lesion, composed of areas of papillary renal cell carcinoma and  areas of mucinous tubular and spindle cell carcinoma.
F/U MRI demonstrated residual disease at the surgical site 93 cm) and theleft inferior abdominal wall at the site of surgical approach (4cm).
Underwent Cyberknife treatment on [**2128-7-6**] to the tumor bed recurrence region, though follow-up CT revealed metastatic spread of disease.
Given recurrent erosion into duodenum and persistent periduo abscess pt underwent roux-en-y duodenojejunostomy and CCY [**2129-8-16**].
The tumor cells are positive for keratin cocktail (AE1/AE3; CAM 5.2 ),vimentin,PAX-2, P504s (Amacar) and mucicarmine.
The tumor is negative for CK7, CK20, CD10 and P63.
[**2129-8-28**] CT HEAD W/ CONTRAST No evidence for metastasis.
Duo anastomosis visualized & ulcerated mass--likely tumor.
[**2129-8-19**]:  PT again transfused 2 units PRBC for HCT of 22.
[**2129-8-27**]   Radiology PORTABLE ABDOMEN, CXR Code blue called because PT non responsive, HR 190s Bp 110 systolic, iV lopressor pushed x 2.
[**2129-8-28**] INPT GI CONSULT, CT HEAD W/ CONTRAST, New Picc line placed by IV team.
EGD  performed  with ulcerated tumor mass in duodenum.
Medications on Admission: Hyoscyamine 0.125''', ms contin 30-60 q8prn, morphine 15mg q4h prn, omeprazole 20'', zofran 4 q8prn, miralax, compazine  Discharge Medications: 1.
Sodium Chloride 0.9%  Flush 10 mL IV PRN line flush Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and PRN.
Followup Instructions: Provider: [**Name10 (NameIs) 1948**] [**Last Name (NamePattern4) 1949**], MD Phone:[**Telephone/Fax (1) 463**] Date/Time:[**2129-9-20**] 1:20    Completed by:[**2129-9-12**
